Wellness Wire Moldova
SEE OTHER BRANDS

Get your fresh news on health and wellness in Moldova

Wellness Wire Moldova: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Moldova.

Press releases published on July 22, 2025

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer

Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today …

DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines

DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines

Châtillon, France, le 22 juillet (22 :30 CEST) 2025 DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— CUSIP: 23306J309), …

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference …

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis   50 mg once-daily dose of obefazimod led to a …

Amwell® to report second quarter 2025 operating results;  company leaders to attend upcoming investor conferences

Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on …

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025

WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Sanuwave Health to Present at Canaccord Genuity Growth Conference

Sanuwave Health to Present at Canaccord Genuity Growth Conference

EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th …

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will …

Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight

Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight

New York, USA, July 22, 2025 (GLOBE NEWSWIRE) -- Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight  The melanoma market is predicted to surge during the forecast period ( …

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 22 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in …

Inovedis Hits 50-Case Milestone with SINEFIX™, a Breakthrough in Rotator Cuff Repair

Inovedis Hits 50-Case Milestone with SINEFIX™, a Breakthrough in Rotator Cuff Repair

MINNEAPOLIS, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Inovedis Inc., an innovative orthopedic technology company, today announced the completion of 50 successful surgeries using its SINEFIX™ Rotator Cuff Repair System in the U.S., a major milestone that …

Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention 

Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention 

New Taipei City, Taiwan, July 22, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated …

HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder

HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder

Study Initiation Marks Key Milestone in Advancing Precision Psychiatry Treatment for Major Depressive Disorder Topline Results Anticipated in the First Half of 2026 MUNICH, Germany and SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- HMNC …

American Gene Technologies Announces Promising Results from AGT103-T HIV Functional Cure Program Presented as Late-Breaker at International AIDS Society 2025

American Gene Technologies Announces Promising Results from AGT103-T HIV Functional Cure Program Presented as Late-Breaker at International AIDS Society 2025

ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), a clinical-stage biotechnology company focused on cell and gene therapies for infectious diseases, today announced compelling new data from its HIV cure program, AGT103-T, …

DoseSpot Collaborates with Amazon Pharmacy to Improve Prescription Medication Pricing Transparency, Give Patients More Fulfillment Options

DoseSpot Collaborates with Amazon Pharmacy to Improve Prescription Medication Pricing Transparency, Give Patients More Fulfillment Options

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions to more than 250,000 users weekly, today announced its collaboration with Amazon Pharmacy, a full- …

A Safer Plate for Every Patient

A Safer Plate for Every Patient

Mississauga, ON, July 22, 2025 (GLOBE NEWSWIRE) -- Celiac Canada is proud to announce a new partnership with Conagra Brands Canada to support the expansion of gluten-free food service in healthcare and long-term care facilities. This collaboration aims to …

Betterguards Forms Strategic Alliance with NBATA to Accelerate Injury Prevention & Recovery Innovation

Betterguards Forms Strategic Alliance with NBATA to Accelerate Injury Prevention & Recovery Innovation

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Betterguards, a sports technology innovator redefining performance and injury prevention, announces a new partnership with the National Basketball Athletic Trainers Association (NBATA). Through the partnership, …

Solera Health Expands Capabilities in Insights Through Unique Machine Learning Predictive Models – Driving Improvements in Care Outcomes and Costs

Solera Health Expands Capabilities in Insights Through Unique Machine Learning Predictive Models – Driving Improvements in Care Outcomes and Costs

PHOENIX, July 22, 2025 (GLOBE NEWSWIRE) -- Solera Health, a premier digital health technology platform and digital care delivery network, announces the addition of Solera Precision Insight Suite. The Solera Precision Insight Suite is a unique machine …

NeOnc Technologies Executes Sub-License Agreement, Marking Key Milestone Toward Closing $50 Million Strategic Partnership with Quazar Investment

NeOnc Technologies Executes Sub-License Agreement, Marking Key Milestone Toward Closing $50 Million Strategic Partnership with Quazar Investment

CALABASAS, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI), a clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, today announced it has achieved a key …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service